Sight Sciences to Report Third Quarter Financial Results on November 7, 2024
Sight Sciences (Nasdaq: SGHT), an eyecare technology company, has announced it will report its third quarter financial results for the period ended September 30, 2024, after the market close on Thursday, November 7, 2024. The company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day to discuss the results.
Investors can access a live and archived webcast of the event on the company's website at www.sightsciences.com, in the News & Events section of the Investors page. The webcast will be available for replay for at least 90 days after the event.
Sight Sciences (Nasdaq: SGHT), un'azienda tecnologica nel settore dell'eyecare, ha annunciato che riporterà i suoi risultati finanziari del terzo trimestre per il periodo conclusosi il 30 settembre 2024, dopo la chiusura del mercato giovedì 7 novembre 2024. L'azienda ospiterà una trasmissione in conferenza alle 13:30 ora del Pacifico / 16:30 ora dell'Est dello stesso giorno per discutere i risultati.
Gli investitori possono accedere a un webcast dal vivo e registrato dell'evento sul sito web dell'azienda all'indirizzo www.sightsciences.com, nella sezione Notizie e Eventi della pagina Investors. Il webcast sarà disponibile per la visione per almeno 90 giorni dopo l'evento.
Sight Sciences (Nasdaq: SGHT), una empresa de tecnología en cuidado ocular, ha anunciado que informará sobre sus resultados financieros del tercer trimestre para el período que finalizó el 30 de septiembre de 2024, después del cierre del mercado el jueves 7 de noviembre de 2024. La compañía llevará a cabo una conferencia telefónica a la 1:30 p.m. hora del Pacífico / 4:30 p.m. hora del Este el mismo día para discutir los resultados.
Los inversionistas pueden acceder a un webcast en vivo y archivado del evento en el sitio web de la compañía en www.sightsciences.com, en la sección de Noticias y Eventos de la página de Inversores. El webcast estará disponible para su repetición durante al menos 90 días después del evento.
사이트 사이언스 (Nasdaq: SGHT), 안과 기술 회사는 2024년 9월 30일 종료된 기간에 대한 3분기 재무 결과를 2024년 11월 7일 목요일 시장 폐장 후 발표할 것이라고 발표했습니다. 회사는 같은 날 태평양 표준시로 오후 1:30, 동부 표준시로 오후 4:30에 컨퍼런스 콜을 주최하여 결과를 논의할 것입니다.
투자자들은 www.sightsciences.com의 뉴스 및 이벤트 섹션에 있는 회사 웹사이트에서 이벤트의 실시간 및 아카이브 웹캐스트에 접근할 수 있습니다. 웹캐스트는 이벤트 후 최소 90일 동안 재생 가능할 것입니다.
Sight Sciences (Nasdaq: SGHT), une entreprise technologique dans le domaine des soins oculaires, a annoncé qu'elle publierait ses résultats financiers du troisième trimestre pour la période se terminant le 30 septembre 2024, après la clôture des marchés le jeudi 7 novembre 2024. L'entreprise organisera un appel conférence à 13h30 heure du Pacifique / 16h30 heure de l'Est le même jour pour discuter des résultats.
Les investisseurs peuvent accéder à un webinaire en direct et archivé de l'événement sur le site Web de l'entreprise à www.sightsciences.com, dans la section Actualités et Événements de la page Investisseurs. Le webinaire sera disponible en rediffusion pendant au moins 90 jours après l'événement.
Sight Sciences (Nasdaq: SGHT), ein Technologieunternehmen im Bereich Augenheilkunde, hat angekündigt, dass es seine Finanzberichte für das dritte Quartal für den Zeitraum bis zum 30. September 2024, nach Marktschluss am Donnerstag, den 7. November 2024, bekannt geben wird. Das Unternehmen wird am selben Tag um 13:30 Uhr Pacific Time / 16:30 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen.
Anleger können auf ein live und archiviertes Webcast der Veranstaltung über die Website des Unternehmens unter www.sightsciences.com zugreifen, im Bereich Nachrichten und Veranstaltungen der Investorenseite. Das Webcast wird mindestens 90 Tage nach der Veranstaltung verfügbar sein.
- None.
- None.
MENLO PARK, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today announced it will report financial results for the third quarter ended September 30, 2024, after the market close on Thursday, November 7, 2024. The Company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.sightsciences.com, on the Investors page in the News & Events section. The webcast will be available for replay for at least 90 days after the event.
About Sight Sciences
Sight Sciences is an eyecare technology company focused on developing and commercializing innovative and interventional solutions intended to transform care and improve patients’ lives. Using minimally invasive or non-invasive approaches to target the underlying causes of the world’s most prevalent eye diseases, Sight Sciences seeks to create more effective treatment paradigms that enhance patient care and supplant conventional outdated approaches. The Company’s OMNI® Surgical System is an implant-free glaucoma surgery technology (i) indicated in the United States to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and (ii) CE Marked for the catheterization and transluminal viscodilation of Schlemm’s canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma. Glaucoma is the world’s leading cause of irreversible blindness. The SION® Surgical Instrument is a bladeless, manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The Company’s TearCare® System is 510(k) cleared in the United States for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (“MGD”), enabling clearance of gland obstructions by physicians to address the leading cause of dry eye disease. Visit www.sightsciences.com for more information.
Sight Sciences and TearCare are trademarks of Sight Sciences registered in the United States. OMNI and SION are trademarks of Sight Sciences registered in the United States, European Union and other territories.
© 2024 Sight Sciences. All rights reserved.
Media contact:
pr@SightSciences.com
Investor contact:
Philip Taylor
Gilmartin Group
415.937.5406
Investor.Relations@Sightsciences.com
FAQ
When will Sight Sciences (SGHT) report its Q3 2024 financial results?
What time is the Sight Sciences (SGHT) Q3 2024 earnings conference call?
How can investors access Sight Sciences' (SGHT) Q3 2024 earnings call?
How long will the webcast of Sight Sciences' (SGHT) Q3 2024 earnings call be available?
